Dr. Hochheiser studies techniques and medications that help patients with severe lung diseases, especially when they are undergoing surgery. One of his primary areas of research involves the use of inhaled epoprostenol, a medication that can improve breathing and oxygen levels in patients who may have only one functioning lung during surgery. By exploring how this drug can be used in conjunction with other treatments, he aims to enhance patient care in high-stakes medical environments.
Key findings
Inhaled epoprostenol can improve oxygen levels during one-lung ventilation, leading to better outcomes for patients with severe lung diseases.
This approach has shown a significant impact on oxygenation status, which is crucial in complex surgical situations.
Frequently asked questions
Does Dr. Hochheiser study lung diseases?
Yes, he specializes in treating patients with severe lung diseases, particularly during surgeries.
What treatments has Dr. Hochheiser researched?
He has researched the use of inhaled epoprostenol to improve breathing and oxygenation in surgical patients.
Is Dr. Hochheiser's work relevant to patients undergoing surgery?
Absolutely, his research directly helps patients with severe lung conditions who require surgery.
Publications in plain English
Inhaled epoprostenol during one-lung ventilation.
2010
The Annals of thoracic surgery
Raghunathan K, Connelly NR, Robbins LD, Ganim R, Hochheiser G +1 more
Plain English This study looked at how inhaling a drug called epoprostenol, combined with another medication given through an IV, can help patients breathe better when they have one lung being used during surgery. The researchers found that this approach can improve oxygen levels in patients who have severe lung diseases. This matters because enhancing oxygenation can lead to better outcomes during complex surgeries.
Who this helps: This helps patients with severe lung disease undergoing surgery.